Yahoo Web Search

  1. Yahoo Finance Results

  2. Bristol-Myers Squibb Company BMY announced that the European Commission (EC) has approved the label expansion of oncology drug Sprycel. Consequently, the drug is ...

  3. Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics

    Motley Fool via Yahoo FinanceJun 29 12:17 PM

    The company has been working on completing Chemistry Manufacturing and Control technical requirements for a planned pivotal phase 3 clinical study evaluating gene therapy Ad-RTS-hIL-12 ...

    56.86+0.23 (+0.40%)

    at Wed, Jul 18, 2018, 13:28PM EST - U.S. Markets close in 1 hr 33 mins

    Nasdaq Real Time Price

    • Open 56.58
    • High 56.91
    • Low 56.30
    • Prev. Close 56.63
    • 52 Wk. High 49.96
    • 52 Wk. Low 49.96
    • P/E 101.35
    • Mkt. Cap 92.93B
  4. Predicting the future is easy. Market research firm EvaluatePharma has done just that with its recently published report that projects the top-selling drugs in the world in 2024.

  5. 3 Reasons BeiGene Needs to Be on Your Radar

    Motley Fool via Yahoo FinanceJul 04 2:45 AM

    We've seen nearly all of big pharma -- including Roche, Bristol-Myers Squibb, and AbbVie (NYSE: ABBV) -- dedicating billions of dollars to develop the next wave of IO drugs ...

  6. 3 Top Healthcare Stocks to Buy Right Now

    Motley Fool via Yahoo FinanceJun 28 12:51 PM

    Investing in the healthcare sector can sometimes feel like riding a roller coaster, but there's little denying that the sector tends to outperform over time. Over the last 11 years, the healthcare ...

  7. The biggest news this week was Novartis’ NVS announcement of its plans to spin off its eye care division, Alcon, into a new public company. The Committee for Medicinal Products for Human ...

  8. Better Buy: Amgen Inc. vs. Pfizer Inc.

    Motley Fool via Yahoo FinanceJul 01 10:32 AM

    Amgen Inc. (NASDAQ: AMGN) and Pfizer Inc. (NYSE: PFE) actually have quite a bit in common. Do Amgen and Pfizer present the same opportunities for investors? You might think that Amgen's current ...

  9. Here's Why Illumina Stock Has Gained 28.3% in 2018 (So Far)

    Motley Fool via Yahoo FinanceJul 06 13:52 PM

    While that's now bringing back the age-old debate over the premium valuation of shares, the company has announced quite a few operational updates to keep Wall Street abuzz with excitement ...

  10. AstraZeneca (AZN.L) suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit. Soriot and his team ...

  11. Hitting cancer early: AstraZeneca's bid to outmaneuver rivals

    Reuters via Yahoo FinanceJul 06 10:47 AM

    AstraZeneca (AZN.L) suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit. Soriot and his team ...

  1. Ads
    related to Bristol-Myers Squibb Company